Description:
Bellco Srl introduces the RAPIDO Hollow-Fibre Dialyzers, a state-of-the-art piece of medical equipment designed to significantly enhance the dialysis process. This sophisticated kidney function replacement device supports patients suffering from chronic kidney diseases by helping to effectively remove waste products and excess fluid from the blood - a process that healthy kidneys would ordinarily perform.
The device is built upon the innovative 'hollow-fibre' technology, the advantageous format of our dialysis membranes. These specially designed fibres increase the interaction surface between the dialysate and the blood, which in turn promotes efficient toxin removal and improved treatment efficacy.
The RAPIDO Hollow-Fibre Dialyzers by Bellco Srl ensure a higher biocompatibility, reducing undesired reactions during the dialysis session and enhancing patient comfort. With its excellent performance parameters and safety features, it provides for a patient-focused, efficient and reliable dialysis treatment.
Importantly, the quality and effectiveness of the dialysis provided by the RAPIDO Hollow-Fibre Dialyzers offer potential improvements in patient wellbeing and quality of life, making it a preferred choice for medical professionals and healthcare providers.
... Read moreDescription:
The Hemoflow F3 and F4 Dialyzers are state-of-the-art medical devices designed and produced by Fresenius Medical Care Renal Therapies Group LLC to enhance the patient experience of individuals in kidney dialysis. A dialyzer, also referred to as an artificial kidney, plays a crucial role in hemodialysis treatment, aiding the removal of excess waste and water from the blood.
These dialyzers are constructed with optimal balance of efficiency and biocompatibility in mind. They showcase high clearance for both small and medium-sized toxins thanks to the clinically proven Fresenius Polysulfone® membrane, which is renowned for its biocompatibility and outstanding cylindrical pore structure.
Notably, the Hemoflow F3 and F4 Dialyzers are designed for patient safety and exceptional performance. Their prime benefit lies in the fact that they ensure a high rate of endotoxin retention, thereby significantly reducing the risk of inflammation and related complications. Furthermore, these dialyzers can be reused which aids in cost-saving.
In summary, the Hemoflow F3 and F4 Dialyzers by Fresenius Medical Care Renal Therapies Group LLC are beneficial to both healthcare providers and patients through their optimal performance, high biocompatibility, safety, and cost-effectiveness.